-
Signature
-
/s/ Junlin Ho, Attorney-in-Fact for Jeffrey S. Flier
-
Issuer symbol
-
SRRK
-
Transactions as of
-
23 Jun 2025
-
Net transactions value
-
-$585,490
-
Form type
-
4
-
Filing time
-
25 Jun 2025, 16:30:05 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| FLIER JEFFREY S. |
Director |
301 BINNEY STREET, CAMBRIDGE |
/s/ Junlin Ho, Attorney-in-Fact for Jeffrey S. Flier |
25 Jun 2025 |
0001740266 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SRRK |
Common Stock |
Options Exercise |
$439,232 |
+20,316 |
+84% |
$21.62 |
44,386 |
23 Jun 2025 |
Direct |
F1, F2 |
| transaction |
SRRK |
Common Stock |
Sale |
$564,357 |
-17,550 |
-40% |
$32.16 |
26,836 |
23 Jun 2025 |
Direct |
F1, F3, F4 |
| transaction |
SRRK |
Common Stock |
Sale |
$90,547 |
-2,766 |
-10% |
$32.74 |
24,070 |
23 Jun 2025 |
Direct |
F1, F5, F6 |
| transaction |
SRRK |
Common Stock |
Sale |
$369,818 |
-11,136 |
-50% |
$33.21 |
11,136 |
23 Jun 2025 |
By trust |
F1, F7, F8 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SRRK |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-20,316 |
-100% |
$0.000000 |
0 |
23 Jun 2025 |
Common Stock |
20,316 |
$21.62 |
Direct |
F1, F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: